RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+33.89%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.72B
AUM Growth
+$2.72B
(-2.6%)
Cap. Flow
-$414M
Cap. Flow
% of AUM
-15.2%
Top 10 Holdings %
Top 10 Hldgs %
41.91%
Holding
86
New
16
Increased
22
Reduced
27
Closed
9
Top Buys
| 1 |
SLN
Silence Therapeutics
SLN
|
$43.8M |
| 2 |
4D Molecular Therapeutics
FDMT
|
$40.2M |
| 3 |
Keros Therapeutics
KROS
|
$36.6M |
| 4 |
Stoke Therapeutics
STOK
|
$33M |
| 5 |
Immunome
IMNM
|
$24.9M |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
$487M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$115M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$67.7M |
| 4 |
Krystal Biotech
KRYS
|
$40M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$26.4M |
Sector Composition
| 1 | Healthcare | 97.54% |
| 2 | Industrials | 2.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOOK
76
DELISTED
HOOKIPA Pharma
HOOK
| $757K | 0.03% |
1,063,769
| – | – |
|
77
Alpha Teknova
TKNO
$227M
| $434K | 0.02% |
171,453
+10,448
| +6% | +$26.4K |
|
|
SLGC
78
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-370,839
| Closed | -$938K |
|
|
NVTA
79
DELISTED
Invitae Corporation
NVTA
| – | – |
-1,474,026
| Closed | -$924K |
|
|
IMGN
80
DELISTED
Immunogen Inc
IMGN
| – | – |
-16,423,922
| Closed | -$487M |
|
|
MDVL
81
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| – | – |
-692,082
| Closed | -$3.05M |
|
|
RYZB
82
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| – | – |
-1,857,706
| Closed | -$115M |
|
|
SNCE
83
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| – | – |
-990,412
| Closed | -$5.29M |
|
|
BCEL
84
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| – | – |
-442,653
| Closed | -$58.4K |
|
|
85
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
-142,500
| Closed | -$67.7M |
|
86
Charles River Laboratories
CRL
$7.99B
| – | – |
-86,782
| Closed | -$20.5M |
|